CLINICAL_TRIALS
ClinicalTrials.gov record update
Post Marketing Surveillance Study of the Labeled Use of Remicade® (Infliximab) in Patients With Chronic Inflammatory Diseases
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00727298
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:03.508983+00:00
- Published At
- 2012-09-12T00:00:00+00:00
- Record Updated At
- 2015-12-01
- Results Posted At
- 2012-09-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Arthritis, Rheumatoid", "Spondylitis, Ankylosing", "Arthritis, Psoriatic", "Psoriasis", "Crohn\u0027s Disease"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-12-01"- protocolSection.identificationModule.nctId
"NCT00727298"- protocolSection.identificationModule.officialTitle
"Post Marketing Surveillance Study of the Labeled Use of Remicade\u00ae (Infliximab) in Patients With Chronic Inflammatory Diseases"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2012-09-12"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.